Prevention of heparin-induced thrombocytopenia during open heart surgery with iloprost (ZK36374)

Surgery

Volumn 102, Issue 5, 1987, Pages 796-807

  Addonizio Jr , V Paul ^a   Fisher, Carol A ^a   Kappa, Jeffrey R ^a   Ellison, Norig ^a  

^a Division of Cardiothoracic Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; ILOPROST;

HEMOSTASIS; OPEN HEART SURGERY; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA;

ADULT; CARDIOPULMONARY BYPASS; CARDIOVASCULAR AGENTS; EPOPROSTENOL; FIBRINOPEPTIDE A; HEPARIN; HUMAN; ILOPROST; MIDDLE AGE; PLATELET AGGREGATION; PLATELET COUNT; PLATELET FACTOR 4; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THROMBOCYTOPENIA; THROMBOXANE B2;

EID: 0023572382     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Heparin-associated thrombocytopenia
2. Heparin-induced thrombocytopenia, thrombosis, and hemorrhage
3. Heparin: a cause of arterial emboli?
4. Heparin-associated thrombocytopenia
5. Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods
6. Iloprost (ZK 36374), a stable analogue of prostacyclin, preserves platelets during simulated extracorporeal circulation
7. 2 in vitro
8. 1 during in vitro simulation of cardiopulmonary bypass
9. Effects of surface area and composition on the function of human platelets during extracorporeal circulation
10. Morphology and enumeration of human blood platelets
11. Clofibrate reversal of platelet hypersensitivity in hyperbetalipoproteinemia
12. The function of monkey (M. mulatta) platelets compared to platelets of pig, sheep, and man
13. Some effects of fibrinogen degradation products on blood platelets
14. Antiheparin proteins secreted by human platelets. Purification characterization and radioimmunoassay
15. Elevation of platelet factor four in acute myocardial infarction. Measurement by radioimmunoassay
16. The release of a human platelet-specific protein measured by a radioimmunoassay
17. Platelet β-thromboglobulin
18. Studies on the liberation of β-thromboglobulin from human platelets in vitro
19. 2
20. 2 in peripheral blood of patients with Prinzmetal's angina
21. Determination of human fibrino-peptide A by radioimmunoassay in purified systems and in blood
22. Development of antibody-mediated extraction followed by GC/MS (antibody/GC/MS) and its application to iloprost determination in plasma
23. Heparin-induced platelet activation in sixteen surgical patients: diagnosis and management
24. Clinical usefulness of testing for heparin-dependent aggregating factor in patients with suspected heparin-associated thrombocytopenia
25. Thrombocytopenia occurring during the administration of heparin: a prospective study in 52 patients
26. Heparin-induced thrombocytopenia in man
27. Heparin-induced thrombocytopenia
28. Heparin-associated thrombocytopenia: a prospective evaluation of 211 patients
29. Studies on the frequency of heparin-associated thrombocytopenia
30. Heparin-associated thrombocytopenia. In vitro effects of different molecular weight heparin fractions
31. Heterogeneity of heparin lots associated with thrombocytopenia and thromboembolism
32. Effect of heparin fractions on platelet aggregation
33. Heparin-immune thrombocytopenia: evidence for a heparin-platelet complex as the antigenic determinant
34. Immune thrombocytopenia
35. Venous gangrene associated with heparin-induced thrombocytopenia
36. Platelets and extracorporeal circulation
37. The hemostatic mechanism after open heart surgery
38. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective granule release
39. Alterations in blood coagulation and hemostasis during extracorporeal circulation Part I
40. Alterations in blood coagulation and hemostasis during extracorporeal circulation Part II
41. Certain clinical aspects of the use of a pump oxygenator
42. Comparison of bubble and membrane oxygenators in short and long perfusion
43. Platelet function during open heart surgery: comparison of membrane and bubble oxygenator
44. 1 on human platelet function
45. The release of platelet factor 4 and platelet aggregation after ASA and heparin administration
46. Quantitation of platelet preservation with prostanoids during simulated bypass
47. 2 levels during cardiopulmonary bypass
48. 2) as anticoagulant for extracorporeal circulation (ECC)
49. Prostacyclin in cardiopulmonary bypass operations
50. Effects of prostacyclin during cardiopulmonary bypass in man
51. Disadvantages of prostacyclin infusion during cardiopulmonary revascularization
52. Aspirin prevents heparin-induced platelet aggregation in vivo
53. Heparin-induced thrombocytopenia: effect of heparin platelet antibody on platelets
54. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein
55. Extracorporeal circulation in a patient with heparin-induced thrombocytopenia
56. The relationship between thromboxane synthesis and platelet release during simulated extracorporeal circulation
57. Carotid endarterectomy in patients with heparin-induced platelet activation: comparative efficacy of aspirin and iloprost (ZK36374)